2015
DOI: 10.1371/journal.pone.0136139
|View full text |Cite
|
Sign up to set email alerts
|

Sensitivity Analysis of an ENteric Immunity SImulator (ENISI)-Based Model of Immune Responses to Helicobacter pylori Infection

Abstract: Agent-based models (ABM) are widely used to study immune systems, providing a procedural and interactive view of the underlying system. The interaction of components and the behavior of individual objects is described procedurally as a function of the internal states and the local interactions, which are often stochastic in nature. Such models typically have complex structures and consist of a large number of modeling parameters. Determining the key modeling parameters which govern the outcomes of the system i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
25
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(32 citation statements)
references
References 67 publications
7
25
0
Order By: Relevance
“…In addition to the ability to facilitate the development and use of increasingly sophisticated ABMs, there have also been methodological improvements for both improving ABMs as well as analyzing the output of simulation experiments utilizing them (Figure ). These developments include work on uncertainty quantification in ABMs (Marino, Hogue, Ray, & Kirschner, ), sensitivity analysis in ABMs (Alam et al, ), methods for increasing the computational efficiency of ABMs via “tuneable resolution” (Kirschner, Hunt, Marino, Fallahi‐Sichani, & Linderman, ), the use of Bayesian statistical model checking for parameter estimation in ABMs (Hussain et al, ), the use of optimization algorithms in conjunction with ABMs (Cicchese, Pienaar, Kirschner, & Linderman, ; R. C. Cockrell & An, ), the use of HPC (C. Cockrell & An, ; R. C. Cockrell & An, ; R. C. Cockrell et al, ; Petersen et al, ; Seekhao et al, ), strategies for data‐driven model validation (Renardy et al, ), and the incorporation of model‐based dynamic control discovery (R. C. Cockrell & An, ; Petersen et al, ). These are exciting developments that have, without a doubt, increased the range of biomedical problems and applications to which ABMs could be applied.…”
Section: Methodological and Technological Developmentsmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition to the ability to facilitate the development and use of increasingly sophisticated ABMs, there have also been methodological improvements for both improving ABMs as well as analyzing the output of simulation experiments utilizing them (Figure ). These developments include work on uncertainty quantification in ABMs (Marino, Hogue, Ray, & Kirschner, ), sensitivity analysis in ABMs (Alam et al, ), methods for increasing the computational efficiency of ABMs via “tuneable resolution” (Kirschner, Hunt, Marino, Fallahi‐Sichani, & Linderman, ), the use of Bayesian statistical model checking for parameter estimation in ABMs (Hussain et al, ), the use of optimization algorithms in conjunction with ABMs (Cicchese, Pienaar, Kirschner, & Linderman, ; R. C. Cockrell & An, ), the use of HPC (C. Cockrell & An, ; R. C. Cockrell & An, ; R. C. Cockrell et al, ; Petersen et al, ; Seekhao et al, ), strategies for data‐driven model validation (Renardy et al, ), and the incorporation of model‐based dynamic control discovery (R. C. Cockrell & An, ; Petersen et al, ). These are exciting developments that have, without a doubt, increased the range of biomedical problems and applications to which ABMs could be applied.…”
Section: Methodological and Technological Developmentsmentioning
confidence: 99%
“…In addition to the ability to facilitate the development and use of increasingly sophisticated ABMs, there have also been methodological improvements for both improving ABMs as well as analyzing the output of simulation experiments utilizing them ( Figure 1). These developments include work on uncertainty quantification in ABMs (Marino, Hogue, Ray, & Kirschner, 2008), sensitivity analysis in ABMs (Alam et al, 2015), methods for increasing the computational efficiency of ABMs via "tuneable resolution" (Kirschner, Hunt, Marino, Fallahi-Sichani, & Linderman, 2014), the use of Bayesian statistical model checking for parameter estimation in ABMs (Hussain et al, 2015), the use of optimization algorithms in conjunction with ABMs (Cicchese, Pienaar, Kirschner, & Linderman, 2017;R. C. Cockrell & An, 2018), the use of HPC (C. Cockrell & An, 2017; R. C. Cockrell & An, 2018;R.…”
Section: Methodological and Technological Developmentsmentioning
confidence: 99%
“…The analysis of this type of system dynamics has been carried out using computational modelling techniques (Christley et al, 2015). Such computational models have been used to describe the spatiotemporal interactions between pathogens, T cells, macrophages, dendritic cells and epithelial cells during infection (Wendelsdorf et al, 2012;Alam et al, 2015). Simulations of experimentally inaccessible scenarios have for instance predicted that the removal of neutrophils and epithelialderived anti-microbial compounds would enhance commensal bacteria growth and promote recovery against Clostridium difficile infection (Leber et al, 2015).…”
Section: Mathematical and Computational Modelling To Study Microbial-mentioning
confidence: 99%
“…Parameter sensitivity analysis can then be used to establish how readily the network function becomes critical as a parameter is changed. In the context of immunology, sensitivity analysis has, for instance, been used to evaluate the influence of maternal adaptive immunity on the time dependence of infection and on its consequences for serology (44) to identify the relative importance of the molecular components in coupled MAPK and PI3K signal transduction pathways (45), for the NF-κB signaling network (46), in an immune-based model of Helicobacter pylori infection (47), and in analyzing the T cell response to antigen (48). An approach related to sensitivity analysis is metabolic control analysis, which is limited to sensitivities with respect to process activities (49)(50)(51).…”
Section: Introductionmentioning
confidence: 99%